U.S. Beverage Stock News

Recently at Madison Square Garden, the Professional Women’s Hockey League drew a sold-out crowd of 18,006 fans for its debut game, setting a new U.S. attendance record for women’s hockey and marking the first women’s professional hockey event at the venue. This record turnout underlines growing enthusiasm for women’s sports and highlights Madison Square Garden Sports’ ability to attract high-demand events that can enhance its event-driven revenue mix and brand strength. With record women’s...

In March 2026, Critical Metals Corp. reported that 2025 metallurgical test work at Fremantle Metallurgy in Perth successfully replicated and improved on 2016 Tanbreez results, delivering an outstanding 2.96% TREO and HREO refined concentrate using an updated high‑gauss magnetic separation flowsheet. This advancement, reviewed by independent consultant Professor Tony Tang, replaces the prior PEA flowsheet and supports the transition toward pilot plant operations and a 150‑tonne bulk sample...

Etsy recently announced that it will ban the sale of products containing animal fur from animals killed for their pelts, effective August 11, 2026, following pressure from animal rights activists and as part of its sustainability agenda. This fur-free policy, which still allows materials like leather, wool, and taxidermy, underscores Etsy’s push to align its marketplace with ethical sourcing and evolving consumer expectations around biodiversity and animal welfare. We’ll now examine how...

In late March 2026, Hudson Technologies announced a licensing agreement with Solstice Advanced Materials to reclaim and resell Solstice’s patented lower-GWP HFO refrigerant blends R-448A and R-449A across the United States and Canada under AIM Act-compliant applications in the supermarket segment. This agreement gives Solstice broader access to the refrigeration retrofit market while aligning its technology with tightening environmental regulations on higher-GWP refrigerants. Next, we’ll...

Alphabet (GOOGL) is back in focus after Google Cloud’s strong AI driven momentum, the launch of the TurboQuant compression algorithm, and a fresh long term custom AI chip agreement with Broadcom. See our latest analysis for Alphabet. That backdrop helps explain why Alphabet’s 1-day share price return of 1.43% and 7-day share price return of 9.69% stand out next to a 90-day share price return of a 4.57% decline, while the 1-year total shareholder return of 105.13% points to strong longer term...

American Assets Trust (AAT) recently reworked its credit agreement, increasing total unsecured borrowing capacity to $600 million and extending key debt maturities to 2030, a material funding shift for investors to track. See our latest analysis for American Assets Trust. At a share price of $18.50, recent moves around the amended credit facility and the upcoming first quarter 2026 earnings call sit against a 1 year total shareholder return of 9.54%, with a 22.50% total shareholder return...

Jamie Dimon has released his 2025 annual letter to JPMorgan Chase shareholders, focusing on rising geopolitical and economic risks. The letter outlines a multi trillion dollar Security and Resiliency Initiative and calls for regulatory reforms tied to national economic security. Dimon also details JPMorgan's plans for rapid AI adoption, including its impact on operations and the workforce, alongside recent leadership changes. JPMorgan Chase, NYSE:JPM, enters this latest news cycle with a...

Tanger Inc. has announced that at its 2026 Annual Meeting, long-time Chair Steven B. Tanger will retire and become Chair Emeritus, with independent director Luis Ubiñas assuming the role of Non-Executive Chair while Bridget Ryan-Berman steps down as Lead Independent Director but remains on the Board. This shift marks a governance milestone as Tanger moves from founder-family board leadership toward an independent chair with extensive corporate, advisory, and foundation experience spanning...

Why BofA’s New Coverage Matters For Payoneer Global (PAYO) BofA’s decision to initiate coverage of Payoneer Global (PAYO) with a favorable view puts fresh attention on the stock and highlights its role in cross border payments for small and medium sized businesses. See our latest analysis for Payoneer Global. Despite BofA’s positive coverage, momentum has been mixed. There has been a 7 day share price return of 3.14% and a 30 day share price return of 4.68%, set against a 1 year total...

In early April 2026, reports that the US government may impose tariffs of up to 100% on imports of branded and patented drugs, focusing on companies that have not agreed to lower prices, triggered a broad reassessment of regulatory and cost risks across the pharmaceutical industry. This policy debate matters for Collegium Pharmaceutical because it highlights how fast-changing US drug-pricing and trade actions can influence sentiment toward specialty pain and CNS drug makers, even when their...

In late March 2026, OLAY unveiled research at the American Academy of Dermatology meeting highlighting cell adhesion as a key driver of visible skin aging, while Dawn rolled out a redesigned refill jug and upgraded Platinum formula aimed at faster, easier dishwashing. Together, these science-focused upgrades in premium skin care and everyday home care illustrate how Procter & Gamble is using research and design to refresh core brands. Next, we’ll examine how OLAY’s cell-adhesion science and...

Tenable Holdings (TENB) has drawn attention after launching Tenable Hexa AI, an agentic AI engine for its Tenable One Exposure Management Platform that automates security workflows and coordinates cyber risk reduction across complex environments. See our latest analysis for Tenable Holdings. The Tenable Hexa AI launch comes after a sharp pullback, with a 30 day share price return of a 12.26% decline and a 90 day share price return of a 20.74% decline, while the 1 year total shareholder return...

What recent performance says about Sally Beauty Holdings (SBH) Sally Beauty Holdings (SBH) has drawn attention after recent share price pressure, with the stock showing a 9.6% decline over the past month and a 12.1% decline over the past 3 months. See our latest analysis for Sally Beauty Holdings. Despite the recent 30 day share price return of negative 9.6% and a 90 day share price return of negative 12.1%, the 1 year total shareholder return of 57.7% suggests earlier optimism that now...

In late March 2026, nCino, Inc. reported fourth-quarter and full-year results showing higher revenue and a move from a net loss to net income, alongside new guidance for fiscal 2027 and completion of a US$25,000,000 share repurchase covering 967,571 shares. The company also filed a US$98.55 million employee share offering shelf, appointed experienced revenue leader Keith Kettell as Chief Revenue Officer, and continued to win new banking clients such as Luana Savings Bank to modernize lending...

Regulatory spotlight on Freshpet after advertising ruling The recent move in Freshpet (FRPT) was sparked by a National Advertising Division ruling that its dog food ads should drop or revise "human grade" claims, followed by securities law investigations and a sharp share price reaction. See our latest analysis for Freshpet. Beyond the immediate reaction to the advertising ruling and legal investigations, Freshpet’s 1 month share price return of 28.59% decline and 1 year total shareholder...

Recently, analysts raised their full-year earnings projections for China Yuchai International by 40.5%, while the company’s year-to-date return has outpaced both the broader Auto-Tires-Trucks sector and its Automotive - Original Equipment peers. This combination of sharply upgraded earnings expectations and clear relative performance strength suggests analysts and investors are reassessing the company’s profit and competitive outlook. We’ll now explore how this upgrade in earnings...

Edwards Lifesciences (EW) put fresh clinical data for its EVOQUE tricuspid valve system in the spotlight at the ACC.26 conference, highlighting sustained patient benefits and lower mortality in the TRISCEND II trial. See our latest analysis for Edwards Lifesciences. At a share price of $81.19, Edwards Lifesciences has seen a 17.67% 1 year total shareholder return. The 90 day share price return of a 5.43% decline suggests recent momentum has cooled despite supportive EVOQUE trial headlines. If...

Why Carlisle Companies is on investors’ radar today Carlisle Companies (CSL) is drawing attention after recent share price moves, with the stock showing a mix of modest gains over the past week alongside weaker performance over the past month and past 3 months. Those shifts are prompting closer scrutiny of its US$13.5b market value, current price near US$331, and broader context as a building envelope products manufacturer with operations across the United States, Europe and other...

Timken: key performance markers investors are watching Timken (TKR) has drawn fresh attention after recent share moves, with the stock showing mixed returns over the past week, month and past 3 months while longer term performance and profitability metrics present a different picture. See our latest analysis for Timken. At a share price of $98.94, Timken’s recent 7 day share price return of 3.13% contrasts with a modest 30 day share price pullback, while the 1 year total shareholder return of...

Scholar Rock Holding (SRRK) has resubmitted its Biologics License Application for apitegromab to the FDA, following alignment with regulators on facility remediation and the addition of a second US based fill finish site. See our latest analysis for Scholar Rock Holding. The BLA resubmission appears to have kept attention on Scholar Rock, with a 7 day share price return of 13.3% and an 18.16% 90 day share price return. The 1 year total shareholder return of 87.44% points to strong momentum...

In recent months, Ormat Technologies has outlined plans to add 149 MW of new capacity by the end of 2027, including 101 MW from geothermal projects, while committing US$180 million to build additional energy storage assets in the United States through 2028. This combination of geothermal expansion and sizable storage investment highlights Ormat’s effort to deepen its role in supplying grid-stable renewable power as adoption of clean energy accelerates. Next, we’ll explore how Ormat’s planned...

Why CNA Financial (CNA) Is Back in Focus After Its Latest Quarter CNA Financial (CNA) has drawn fresh attention after quarterly results came in below market expectations, with weaker core earnings per share and profitability despite growth in premiums and investment income. At the same time, management raised the regular dividend by 4% and announced a special dividend. This move highlights confidence in ongoing cash generation, even as underwriting performance and higher expenses remain key...

In recent weeks, Meta Platforms has faced major legal setbacks as US juries in California and New Mexico found its social media products liable for addictive design harms to minors, resulting in multimillion‑dollar penalties and fresh scrutiny of its platform practices. These rulings mark one of the first times a large social network has been treated as a potentially defective product under US product liability law, opening the door to broader challenges against how Meta engineers engagement...

Why AXT’s share authorization move matters for investors AXT (AXTI) is back in focus after proposing a sizable increase in authorized common shares, from 70,000,000 to 120,000,000, ahead of its May 14, 2026 annual stockholder meeting. See our latest analysis for AXT. The latest share authorization proposal comes after a sharp pullback, with a 1 day share price return of negative 20.53%, a 90 day share price return of 108.18%, and a 1 year total shareholder return that is very large. Recent...